HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy

Killer-cell immunoglobulin-like receptors (KIRs) are a family of glycoproteins expressed primarily on natural killer cells that can regulate their function. Inhibitory KIRs recognize MHC class I molecules (KIR-ligands) as ligands. We have reported associations of KIRs and KIR-ligands for patients in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Immunol
Hauptverfasser: Erbe, Amy K., Wang, Wei, Reville, Patrick K., Carmichael, Lakeesha, Kim, KyungMann, Mendonca, Eneida A., Song, Yiqiang, Hank, Jacquelyn A., London, Wendy B., Naranjo, Arlene, Hong, Fangxin, Hogarty, Michael D., Maris, John M., Park, Julie R., Ozkaynak, M. F., Miller, Jeffrey S., Gilman, Andrew L., Kahl, Brad, Yu, Alice L., Sondel, Paul M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2017
Schlagworte:
Immunology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5466980/
https://ncbi.nlm.nih.gov/pubmed/28659916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.00675
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge